-
CSR Summary Not Yet Available
-
NCT01381874
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameAbiraterone acetateProduct NameZYTIGA®Therapeutic AreaCancers and Other NeoplasmsEnrollment297% Female100%% White88.9%
Product ClassHormonesSponsor Protocol Number212082BCA2001Data PartnerJohnson & JohnsonCondition StudiedNeoplasms, BreastMean/Median Age (Years)62.9
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available